Broda Tech News
The effectiveness of medication depends on the method of administration
Treatments can often be improved by finding optimal drug formulations or delivery systems.

New US Patent Granted for a Supramolecular Smart Drug Delivery Technology

Shanghai, China, March 14, 2017 – Broda Technologies Co., Ltd. today announced it has been granted a new US Patent 9,592,295 on March 14 for a patent titled “Reversely Thermal-Reversible Hydrogel Compositions”.
The patent extends the coverage of Company’s key IntelliGel® supramolecular smart drug delivery technology and its application in pharmaceutical, cosmetic and personal care products.

“The granting of a new US patent for the supramolecular smart drug delivery technology broadens our coverage for the technology. IntelliGel® supramolecular smart drug delivery system has wide potential applications with enhanced efficacy, patient compliance, and safety compared with existing pharmaceutical and cosmetic products.” stated Broda Technologies’ President Dr. Shao Xiang Lu.

About Broda Technologies
Broda Technologies Co. Ltd. is a small technology company focus on supramolecular smart drug delivery technology and the development of related products. The Company’s proprietary IntelliGel® supramolecular smart drug delivery system is capable of dissolving water insoluble or sparely soluble drugs with sustained release in a clear and transparent thermo-responsive hydrogel for enhanced efficacy, safety and patient’s compliance. For more information, please visit www.brodatech.com.

Contact
Broda Technologies Co., Ltd.
Shao Xiang Lu, Ph.D.
China Tel: +86 21 2022 5388
US Tel: +1 609-779-1257
E-mail: info@brodatech.com